PCPs prescribe drug more
Among the male new tamsulosin users, primary care physicians initiated 31.6% of tamsulosin prescriptions, urologists initiated 18.0%, and emergency medicine physicians initiated 11.5%.
Some 85.3% of male new tamsulosin users had at least one targeted comorbidity in the 12 months before tamsulosin initiation. These targeted comorbidities were hypertension in 44.8%, dyslipidemia in 41.2%, kidney stones in 31.9%, heart disease in 17.4%, and diabetes in 16.5%.
“Tamsulosin has been used for the treatment of stones to increase the spontaneous stone passage rate, and the community of medical practitioners has taken this on,” said Dr. Kava. “Certainly, a lot of investigation needs to be done into the use for female voiding disorders and for urolithiasis.”
A credentialing process to ensure appropriate tamsulosin use by non-urologists may be beneficial, he believes.
“I’m not aware of any curriculum that primary care doctors have to take to show a mastery of urologic problems,” Dr. Kava said. “I am working with the American Society of Men’s Health to develop a curriculum for men’s health issues, and certainly that can be adopted by primary care physicians, emergency room doctors, and urologists.”
One of Dr. Kava’s co-authors is an employee of Boehringer-Ingelheim, and another co-author is an investigator for that company. Another co-author is an investigator for Ixchelsis Ltd.
More on BPH:
Subscribe to Urology Times to get monthly news from the leading news source for urologists.